---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-25-009455"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T04:59:11.697895+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Tonix launches 'Move Fibro Forward' awareness campaign for fibromyalgia patients

## Summary
- Tonix Medicines subsidiary launched campaign to support individuals with fibromyalgia.
- No new FDA-approved treatments for fibromyalgia in over 15 years cited as motivation.
- Campaign includes website (movefibroforward.com) and partnerships with patient advocates.
- CEO quotes emphasize commitment to fibromyalgia community and patient visibility.

## SEC filing metadata
- accession: 0001999371-25-009455
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937125009455/0001999371-25-009455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937125009455/tonix-8k_071725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-25-009455
- JSON: https://secwatch.observer/filing/0001999371-25-009455.json
- Plain text: https://secwatch.observer/filing/0001999371-25-009455.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.